PHARMACORP RX INC (PCRX.CA) Stock Income Statement
TSX-V:PCRX - TSX Venture Exchange - CA71714X1050 - Common Stock - Currency: CAD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 578.00K | 563.20K | 26.50K | |||
| Selling, General, and Administrative Expenses | 578.00K | 563.20K | 26.50K | |||
| Operating Income | -578.00K | -563.20K | -26.50K | |||
| Interest Income/Expense | 107.50K | 46.10K | 700.00 | |||
| Income Before Taxes | -470.40K | -517.10K | -25.80K | |||
| Net Income | -470.40K | -517.10K | -25.80K | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.00 | |||
| Statistics | ||||||
All data in CAD